Due
to the abuse of antibiotics, antimicrobial resistance is rapidly
emerging and becoming a major global risk for public health. Thus,
there is an urgent need for reducing the use of antibiotics, finding
novel treatment approaches, and developing controllable release systems.
In this work, a dual synergistic antibacterial platform with on-demand
release ability based on silver nanoparticles (AgNPs) and antimicrobial
peptide (AMP) coloaded porous silicon (PSi) was developed. The combination
of AgNPs and AMPs (Tet-213, KRWWKWWRRC) exhibited an excellent synergistic
antibacterial effect. As a carrier, porous silicon can efficiently
load AgNPs and AMP under mild conditions and give the platform an
on-demand release ability and a synergistic release effect. The AgNPs
and AMP coloaded porous silicon microparticles (AgNPs-AMP@PSiMPs)
exhibited an acid pH and reactive oxygen species (ROS)-stimulated
release of silver ions (Ag+) and AMPs under bacterial infection
conditions because of oxidation and desorption effects. Moreover,
the release of the bactericide could be promoted by each other due
to the interplay between AgNPs and Tet-213. In vitro antibacterial tests demonstrated that AgNPs-AMP@PSiMPs inherited
the intrinsic properties and synergistic antibacterial efficiency
of both bactericides. In addition, wound dressing loaded with AgNPs-AMP@PSiMPs
showed outstanding in vivo bacteria-killing activity,
accelerating wound-healing, and low biotoxicity in aStaphylococcus aureus-infected rat wound model. The
present work demonstrated that PSiMPS might be an efficient platform
for loading the antibiotic-free bactericide, which could synergistically
and on-demand release to fight wound infection and promote wound healing.